1. Home
  2. Blog
  3. Catalogue Update Announcement

Catalogue Update Announcement

Catalogue Update Announcement


Catalogue Update Announcement

Since a funding injection by our investors in 2017, we have been working hard to double our manufacturing capacity and bring some exciting new products to market. Cells will always be the (beating) heart of what we do at Axol, but we know that until now our customers have had to look elsewhere for antibodies, kits and other reagents.

This is why we have invested a lot of time and effort preparing a range of top quality antibodies, assay kits, elisa kits, small molecules and cytokines so we can make our customers’ lives more convenient. Science never sleeps and at Axol we are committed to enabling researchers to do their best work every day by providing only the best quality products and backing them up with world class customer support.

By aligning this improved range of high quality reagents with Axol’s expertise in primary and IPS derived human cells, we take a step closer to achieving our aspiration of being the number one for human cell culture. We take science very seriously and our in-house team of experts, PhDs and technical support are all focused on getting the very best products to our customers.

Right now we are finalising our beta testing ahead of the launch and we are really pleased with the quality of the products. We look forward to hearing the response from our customers through our new product review feature.

Axol, your discovery stems from here.

Enhancing Amyotrophic Lateral Sclerosis (ALS) drug discovery using physiologically relevant hiPSC-Derived Motor Neurons
Using human iPSC-Derived Renal Cells to enhance safety toxicity testing during drug development